Centene Unit Collaborates With RxAdvance for New PBM Platform

Centene CorporationCNC recently announced the implementation of a transformative pharmacy benefit management model through RxAdvance's Collaborative PBM Cloud platform by its Mississippi arm, Magnolia Health. This service is available to 240,000 Mississippi Medicaid members. The collaboration is expected to reduce overall administrative costs and contribute to the betterment of health outcomes by decreasing medical costs.

Earlier this year, the company also informed about a tie-up with RxAdvance, aiming to create an advanced pharmacy management solution. Magnolia Health is the company's first unit that has successfully implemented this model. With the amalgamation of this Pharmacy Solutions business, RxAdvance's unique platform and a new business model, this new solution is likely to be a game-changer. The parent company is also anticipated to provide a value-based care to its members at affordable costs with this transparent Pharmacy Benefit Management model.

The company has been constantly making endeavors to enhance the experience of its members at a low cost. Apart from collaborations, Centene is also actively taking up mergers and acquisitions for the past many quarters for expanding its markets and increasing its Medicaid membership. In March 2016, the company acquired Health Net, which has substantially been accretive to the company's top line.

This year, Centene bought Community Medical Holdings, MHM Services and Fidelis Care. In July 2018, the company entered into a joint venture with Ascension to establish a Medicare Advantage plan, which will be operational across multiple geographic markets beginning 2020. These acquisitions and partnership should bolster the company's operations and aid long-term growth.

Shares of this Zacks Rank #3 (Hold) have rallied 15.5% in a year's time, outperforming its industry 's growth of 11.6%.

Stocks to Consider

Investors interested in the Medical-HMO industry can check out some better-ranked stocks like Molina Healthcare, Inc MOH , Humana Inc HUM and Anthem, Inc. ANTM .

Molina offers Medicaid-related solutions to meet the health care needs of low-income families and individuals. It sports a Zacks Rank #1 (Strong Buy). In the last four reported quarters, the company delivered average four-quarter beat of 82.55%. You can see the complete list of today's Zacks #1 Rank stocks here .

Humana operates as a health and well-being company in the United States. It carries a Zacks Rank #2 (Buy) and came up with average four-quarter earnings surprise of 4.73%.

Anthem operates as a health benefits company in the United States. A Zacks #2 Ranked player, the company managed to pull off average trailing four-quarter positive surprise of 5.11%.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Humana Inc. (HUM): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Molina Healthcare, Inc (MOH): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More